Technology | EP Mapping and Imaging Systems | January 19, 2018

Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled

New device facilitates rapid, complex arrhythmia diagnosis and enables physicians to map any chamber of the heart to best determine ablation strategy and optimize patient care

Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled

January 19, 2018 — Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping Catheter, Sensor Enabled, a product designed to advance cardiac mapping during cardiac ablation to treat patients with complex cardiac arrhythmias. With the European launch of this latest addition to Abbott’s electrophysiology portfolio, the company is offering physicians a mapping catheter with what it calls a first-of-its-kind grid configuration of electrodes for improved data collection that supports the creation of high-density mapping of cardiac tissue to support optimal treatment for patients.

For patients battling complex arrhythmias, physicians may use cardiac ablation therapy to create tiny scars or lesions on the heart to stop erratic electrical signals. Yet to ensure the best outcomes for their patients, physicians first need to identify which areas of the heart are responsible for those signals.  Mapping catheters are critical to providing this insight.

Indicated for use in any chamber of the heart, the Advisor HD Grid mapping catheter is designed to combat challenges sometimes associated with traditional mapping catheters.

Linear or circular mapping catheters may experience signal disruptions as the orientation of the catheter changes. The Advisor HD Grid mapping catheter is intended to help physicians avoid signal loss by allowing for data to be captured horizontally and vertically along a new electrode grid configuration with 16 sensors. As a result, the catheter utilizes high-density mapping to create detailed and anatomically accurate 3-D models of the heart.

Abbott's Advisor HD Grid mapping catheter enables physicians to collect data simultaneously along the catheter’s grid pattern to help optimize treatment decisions. Combined with the EnSite Precision Cardiac Mapping System, the data captured by the catheter is used to create a highly detailed map highlighting the differences between healthy tissue and tissue responsible for a patient's cardiac arrhythmias, such as atrial fibrillation. Such detail can make an important impact on a physician's ablation strategy and approach to patient care.

As an added benefit for physicians, by designing the Advisor HD Grid mapping catheter as Sensor Enabled, Abbott has allowed the catheter to capture data in two ways – through impedance and magnetic collection, improving how data is collected and providing physicians additional flexibility when pairing the catheter with the EnSite Precision Cardiac Mapping System.

For more information: www.sjmglobal.com

 


Related Content

News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
News

May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...

Home May 04, 2022
Home
News

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

Home April 05, 2021
Home
News

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
Home
News

May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF) ...

Home May 08, 2020
Home
Subscribe Now